1 |
Meyer L, Stubbs B, Fahrenbruch C, et al.Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age a 30-year review[J]. Circulation, 2012, 126(126): 1363-1372.
|
2 |
Kazaure HS, Roman SA, Sosa JA.Epidemiology and outcomes of in-hospital cardiopulmonary resuscitation in the United States, 2000-2009[J]. Resuscitation, 2013, 84(9): 1255-1260.
|
3 |
Laver S, Farrow C, Turner D, et al.Mode of death after admission to an intensive care unit following cardiac arrest[J]. Intensive Care Med, 2004, 30(11): 2126-2128.
|
4 |
Nolan JP, Neumar RW, Adrie C, et al.Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication: A scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care;the Council on Clinical Cardiology; the Council on Stroke[J]. Resuscitation, 2008, 79(3): 350-379.
|
5 |
Zheng XF, Sun XJ, Xia ZF.Hydrogen resuscitation, a new cytoprotective approach[J]. Clin Exp Pharmacol Physiol, 2011, 38(3): 155-163.
|
6 |
Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine[J]. Pharmacol Ther, 2014, 144(1): 1-11.
|
7 |
Hayashida K, Sano M, Kamimura N, et al.H(2) gas improves functional outcome after cardiac arrest to an extent comparable to therapeutic hypothermia in a rat model[J]. J Am Heart Assoc, 2012, 1(5): e003459.
|
8 |
Wang P, Jia L, Chen B, et al.Hydrogen inhalation is superior to mild hypothermia in improving cardiac function and neurological outcome in an asphyxial cardiac arrest model of rats[J]. Shock, 2016, 46(3): 312-318.
|
9 |
Konietzke D, Gervais H, Dick W, et al.Models and methods in animal experiments in resuscitation[J]. Der Anaesthesist, 1988, 37(3): 140-149.
|
10 |
Von PI, Weil MH, Von PM, et al.Cardiopulmonary resuscitation in the rat[J]. J App Physiol, 1988, 65(6): 2641-2647.
|
11 |
van Alem AP, Vrenken RH, de Vos R, et al.Use of automated external defibrillator by first responders in out of hospital cardiac arrest: prospective controlled trial[J]. BMJ, 2003, 327(7427): 1312.
|
12 |
Kern KB, Hilwig RW, Berg RA, et al.Postresuscitation left ventricular systolic and diastolic dysfunction.Treatment with dobutamine[J]. Circulation, 1997, 95(12): 2610-2613.
|
13 |
Kern KB, Hilwig RW, Rhee KH, et al.Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning[J]. J Am Coll Cardiol, 1996, 28(1): 232-240.
|
14 |
Laurent I, Monchi M, Chiche JD, et al.Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest[J]. J Am Coll Cardiol, 2002, 40(12): 2110-2116.
|
15 |
Ruiz-Bailén M, Aguayo de Hoyos E, Ruiz-Navarro S, et al.Reversible myocardial dysfunction after cardiopulmonary resuscitation[J]. Resuscitation, 2005, 66(2): 175-181.
|
16 |
Ohsawa I, Ishikawa M, Takahashi K, et al.Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals[J]. Nat Med, 2007, 13(6): 688-694.
|